BIPOLAR DEPRESSION

People with bipolar disorder face double the risk of heart disease and die 14 years earlier on average. This study tests whether a personalized nutrition program—based on Brazil's dietary guidelines—can improve heart health markers like cholesterol, blood sugar, and body fat. Eig…

This study tests deep brain stimulation (DBS) for people with severe bipolar depression that hasn't improved with other treatments. Ten participants will have electrodes surgically placed in their brain and a device implanted in their chest to deliver electrical pulses. The goal …

This study tests whether giving stronger medications earlier can help people with schizophrenia, major depression, or bipolar depression who did not get better with their first treatment. Over 1,200 participants will receive either standard second-line treatment or an intensified…

This study tests whether quickly switching to a more intensive combination of medications helps people with bipolar depression who didn't get better on their first treatment. About 418 adults will either receive standard care or an intensified regimen of antidepressants and mood …

This Phase 3 trial tests whether a daily pill called azetukalner can safely reduce depression in people with bipolar I or II disorder. About 400 adults currently in a depressive episode will take either the drug or a placebo for 6 weeks. Researchers will measure mood changes usin…

This study tests a non-invasive device that uses electrical fields to gently stimulate deep brain areas, aiming to improve depression in people with bipolar disorder. Researchers will compare the real device to a sham version in 160 adults. They will also use brain scans to under…

This pilot study tests whether time-restricted eating (eating all food within a 10-hour window each day) is feasible and acceptable for people with bipolar disorder. 40 participants will either follow the eating schedule or receive nutritional counseling for 8 weeks. The goal is …

This study tests whether a non-invasive brain stimulation technique called intermittent theta-burst stimulation (iTBS) can reduce depression symptoms in people with treatment-resistant bipolar disorder. About 124 participants will receive either real or sham (fake) stimulation da…

This study tests whether a non-invasive device called deep transcranial magnetic stimulation (dTMS) can improve mood and thinking in people with bipolar depression. One hundred adults will receive either real or sham dTMS sessions over four weeks, while continuing their usual med…

This study tests a gentle brain stimulation technique called tDCS to see if it can improve anhedonia—the loss of interest or pleasure—in people with bipolar depression. About 45 adults with bipolar disorder and significant anhedonia will receive tDCS while researchers use brain s…

This study tests whether a strict high-fat, low-carbohydrate (ketogenic) diet can help ease depression in people with bipolar disorder. Thirty adults aged 18 to 50 with bipolar I or II will follow the diet for 8 weeks while researchers track mood changes and heart health. The goa…

This study tests if magnetic seizure therapy (MST) works as well as electroconvulsive therapy (ECT) for people with bipolar depression or treatment-resistant depression. About 60 adults will receive either MST or ECT to see which better reduces depression symptoms with fewer side…

This study tests a gentle, non-invasive brain stimulation method called HD-tDCS in 100 teenagers with bipolar depression. Half get real stimulation, half get a fake version, and both continue their usual medications. Researchers will check if depression scores improve after two w…

This study looks at how tiny changes in your RNA (a molecule that reads your DNA) might help predict whether depression treatments will work. Researchers will follow 120 adults with unipolar or bipolar depression to see if these RNA changes match up with improvements in mood. The…

This study looks at how electroconvulsive therapy (ECT) affects brain connections and sleep in 50 people with treatment-resistant depression. Researchers will measure brain activity during sleep and wakefulness to understand how ECT works. The goal is to learn more, not to test a…

This study is a registry that will follow up to 1,000 adults with treatment-resistant depression or obsessive-compulsive disorder (OCD) who receive electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), or ketamine/esketamine. Researchers will collect data from…